|
|
|
|
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
1652756 |
| 005 |
20080227123200.0 |
| 008 |
940810s1994 gw a b 001 0 eng c |
| 003 |
ICU |
| 010 |
|
|
|a 93044948
|
| 020 |
|
|
|a 354057123X :
|c £430.00
|
| 020 |
|
|
|a 038757123X
|
| 035 |
|
|
|a (ICU)BID19038789
|
| 035 |
|
|
|a (OCoLC)29358406
|
| 040 |
|
|
|a DNLM/DLC
|c DLC
|d DLC
|d ICU$dOrLoB
|
| 050 |
0 |
0 |
|a QP905
|b .H3 vol. 113
|a QR186.85
|
| 060 |
|
0 |
|a W1 HA51L v. 113 1994
|a QW 575 P536 1994
|
| 082 |
|
|
|a 615/.1 s
|a 615/.37
|2 20
|
| 245 |
0 |
4 |
|a The Pharmacology of monoclonal antibodies /
|c contributors, R. Balint ... [et al.] ; editors, Martin Rosenberg and Gordon P. Moore.
|
| 260 |
|
|
|a Berlin ;
|a New York :
|b Springer-Verlag,
|c 1994.
|
| 300 |
|
|
|a xxi, 406 p. :
|b ill. ;
|c 25 cm.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
| 440 |
|
0 |
|a Handbook of experimental pharmacology
|v v. 113
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
0 |
|g Ch. 1.
|t Human Monoclonal Antibody Technology /
|r K. James --
|g Ch. 2.
|t Recombinant Therapeutic Human Monoclonal Antibodies /
|r J. W. Larrick and R. Balint --
|g Ch. 3.
|t Transgenic Approaches to Human Monoclonal Antibodies /
|r N. Lonberg --
|g Ch. 4.
|t Humanization of Monoclonal Antibodies /
|r G. E. Mark and E. A. Padlan --
|g Ch. 5.
|t Applications for Escherichia coli-Derived Humanized Fab' Fragments: Efficient Construction of Bispecific Antibodies /
|r P. Carter, M. L. Rodrigues and M. R. Shalaby --
|g Ch. 6.
|t Immunotoxins /
|r S. H. Pincus --
|g Ch. 7.
|t Antibody-Enzyme Fusion Proteins and Bispecific Antibodies /
|r E. Haber --
|g Ch. 8.
|t Three Generations of Recombinant CD4 Molecules as Anti-HIV Reagents /
|r A. Traunecker and K. Karjalainen --
|g Ch. 9.
|t Chemical and Biological Approaches to Catalytic Antibodies /
|r K. D. Janda and Y.-C. Jack Chen --
|g Ch. 10.
|t The Combinatorial Approach to Human Antibodies /
|r C. F. Barbas III --
|g Ch. 11.
|t Antibodies from Escherichia Coli /
|r A. Pluckthun --
|g Ch. 12.
|t Structure, Function and Uses of Antibodies from Transgenic Plants and Animals /
|r A. Hiatt and M. Hein --
|g Ch. 13.
|t Some Aspects of Monoclonal Antibody Production /
|r R. G. Rupp --
|g Ch. 14.
|t Prospects for Cancer Imaging and Therapy with Radioimmunoconjugates /
|r D. M. Goldenberg, R. D. Blumenthal and R. M. Sharkey --
|g Ch. 15.
|t Clinical Experience with Murine, Human and Genetically Engineered Monoclonal Antibodies /
|r M. N. Saleh, R. M. Conry and F. LoBuglio --
|g Ch. 16.
|t Anti-idiotypic Monoclonal Antibodies: Novel Approach to Immunotherapy /
|r M. Chatterjee, K. A. Foon and H. Kohler.
|
| 650 |
|
0 |
|a Monoclonal antibodies
|0 http://id.loc.gov/authorities/subjects/sh85005650
|
| 650 |
|
2 |
|a Antibodies, Monoclonal
|x pharmacology
|
| 650 |
|
7 |
|a Monoclonal antibodies.
|2 fast
|0 http://id.worldcat.org/fast/fst01025547
|
| 700 |
1 |
|
|a Balint, Robert Frederick
|1 http://viaf.org/viaf/8074588
|0 http://id.loc.gov/authorities/names/n86802474
|
| 700 |
1 |
|
|a Rosenberg, Martin
|1 http://viaf.org/viaf/311741984
|0 http://id.loc.gov/authorities/names/n96072911
|
| 700 |
1 |
|
|a Moore, Gordon P.,
|d 1950-
|1 http://viaf.org/viaf/113824194
|0 http://id.loc.gov/authorities/names/n93804677
|
| 850 |
|
|
|a ICU
|
| 901 |
|
|
|a ToCBNA
|a Analytic
|
| 903 |
|
|
|a HeVa
|
| 903 |
|
|
|a Hathi
|
| 929 |
|
|
|a cat
|
| 999 |
f |
f |
|i 78655060-777e-54bf-a0ce-9451b2ce5e60
|s 4bbfb843-50d4-55c7-8c14-87e60c9c3dac
|
| 928 |
|
|
|t Library of Congress classification
|a QP905.H402 v.113
|l ASR
|c ASR-SciASR
|i 2582466
|
| 927 |
|
|
|t Library of Congress classification
|a QP905.H402 v.113
|l ASR
|c ASR-SciASR
|g Analytic
|e CRERAR
|b H95252008
|i 3119744
|
